Viva Biotech IPO: Just About Supporting the Low-End IPO Price Range
Viva Biotech Holdings (1873 HK) is a leading global contract research organisation (CRO). It has launched its IPO to raise net proceeds of HK$1,232...
670 Views
Viva Biotech (维亚生物) IPO: Valuation Rich Even at Low End
Viva Biotech launched book building today to raise up to USD 194 million via its Hong Kong IPO. In our previous insights, we have discussed the...
657 Views
Viva Biotech IPO Preview: Show Me the Money
Viva Biotech Shanghai Ltd (1577881D HK) is a leading global contract research organisation (CRO). Viva has started pre-marketing for a Hong Kong...
595 Views
Viva Biotech (维亚生物) IPO: Warning Signs from 2018 Numbers (Part 2)
Viva Biotechnology, a China-based drug discovery company, is seeking to raise USD 200m to list on the Hong Kong Stock Exchange. It has recently...
794 Views
Frontage Holding (方达控股) IPO: Updates from 2018 Numbers
Frontage Holding, a contract research organization subsidiary of A-share listed Hangzhou Tigermed Consulting (300347 CH), re-filed to list on the...
760 Views